For pharmaceutical manufacturers, the reliable sourcing of high-quality intermediates is the bedrock of consistent and effective drug production. D-(-)-4-Hydroxyphenylglycine Dane Salt, bearing the CAS number 69416-61-1, stands as a critical pharmaceutical intermediate, particularly for the synthesis of the widely prescribed antibiotic, Amoxicillin. The process of selecting the right supplier for this essential compound requires careful consideration of several key factors.

Firstly, a supplier's ability to consistently provide D-(-)-4-Hydroxyphenylglycine Dane Salt with a minimum purity of 99.5% is non-negotiable. This high level of purity minimizes the presence of unwanted by-products and ensures that the synthesized Amoxicillin meets all necessary quality and safety benchmarks. Manufacturers should look for suppliers who clearly state their assay capabilities and provide documentation to support these claims.

Secondly, compliance with international pharmaceutical standards such as USP, BP, EP, and FCC is a critical factor. Reputable suppliers will not only meet these standards but will also provide the necessary certifications and documentation to prove it. This assures manufacturers that the D-(-)-4-Hydroxyphenylglycine Dane Salt they are purchasing is suitable for use in regulated pharmaceutical processes. The availability of detailed product specifications and Safety Data Sheets (SDS) is also a hallmark of a reliable source.

Thirdly, a supplier's reputation and track record in the industry speak volumes. Companies that have a history of reliable delivery, transparent communication, and strong customer support are more likely to be dependable partners. For those looking to buy D-(-)-4-Hydroxyphenylglycine Dane Salt, understanding the supplier's manufacturing capabilities and quality control systems provides added confidence.

The demand for this particular Amoxicillin synthesis intermediate is substantial, making it imperative for manufacturers to establish robust supply chains. By prioritizing suppliers who offer high-purity, compliant D-(-)-4-Hydroxyphenylglycine Dane Salt, pharmaceutical companies can ensure the integrity of their production processes and the quality of their final Amoxicillin products. This careful selection process ultimately contributes to the availability of effective antibiotics for global healthcare needs.